The Skin Health Institute invites individuals who suffer from moderate to severe Eczema (Atopic Dermatitis) to participate in a new research study that is trialling an oral medication that is already approved and used widely in Australia.
If you or someone you know suffers from eczema and is between 18 to 65 years of age, you may be eligible to participate. The duration of the study is over a 33-week period and is aimed at assessing different dosages of an oral medication that is already approved for use in Australia. There is no cost to participate in this study and some study-related expenses will be reimbursed.
Please complete the form below to see if you are eligible for this trial. If you have any questions/queries regarding this trial please email | [email protected]